Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

SRR1421140

GTEX

d62d4afe-3918-56ea-8e00-5dfebd28c0b7

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
GTEX
cancer_type_detailed
subtype
cancer_type
GTEX
sex
Male

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • PROTEIN_SECRETION+0.163
  • DNA_REPAIR+0.131
  • UNFOLDED_PROTEIN_RESPONSE+0.110
  • MITOTIC_SPINDLE+0.099
  • MYC_TARGETS_V2+0.067
  • MYC_TARGETS_V1+0.056
  • PI3K_AKT_MTOR_SIGNALING+0.022
  • SPERMATOGENESIS+0.004
  • OXIDATIVE_PHOSPHORYLATION-0.001
  • KRAS_SIGNALING_DN-0.020

Top 10 suppressed

  • INTERFERON_ALPHA_RESPONSE-0.621
  • INFLAMMATORY_RESPONSE-0.557
  • EPITHELIAL_MESENCHYMAL_TRANSITION-0.551
  • INTERFERON_GAMMA_RESPONSE-0.549
  • ANGIOGENESIS-0.514
  • TNFA_SIGNALING_VIA_NFKB-0.492
  • COAGULATION-0.487
  • IL6_JAK_STAT3_SIGNALING-0.463
  • ALLOGRAFT_REJECTION-0.457
  • COMPLEMENT-0.432

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

10 twins match this tumor's tissue · 0 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR1456841
brain-umap@2
GTEX0.995
2SRR1321244
brain-umap@2
GTEX0.993
3SRR1500537
brain-umap@2
GTEX0.989
4SRR1322270
brain-umap@2
GTEX0.988
5SRR1490382
brain-umap@2
GTEX0.988
6SRR1451897
brain-umap@2
GTEX0.987
7SRR1472621
brain-umap@2
GTEX0.987
8SRR1351325
brain-umap@2
GTEX0.987
9SRR1473185
brain-umap@2
GTEX0.986
10SRR1374246
brain-umap@2
GTEX0.985

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 8 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
PROTEIN_SECRETION0.163Remibrutinib— uncovered
DNA_REPAIR0.131Idelalisib— uncovered
UNFOLDED_PROTEIN_RESPONSE0.110Idelalisib— uncovered
MITOTIC_SPINDLE0.099Inavolisib— uncovered
MYC_TARGETS_V20.067Idelalisib— uncovered
MYC_TARGETS_V10.056Inavolisib— uncovered
PI3K_AKT_MTOR_SIGNALING0.022Inavolisib— uncovered
SPERMATOGENESIS0.004Inavolisib— uncovered